Immunic Inc IMUX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:58 AM EDT
1.31quote price arrow up+0.06 (+4.38%)
Volume
63,612
52 week range
0.95 - 3.11
Loading...
  • Open1.24
  • Day High1.32
  • Day Low1.24
  • Prev Close1.25
  • 52 Week High3.11
  • 52 Week High Date07/05/23
  • 52 Week Low0.95
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap118.004M
  • Shares Out90.08M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-12.67

KEY STATS

  • Open1.24
  • Day High1.32
  • Day Low1.24
  • Prev Close1.25
  • 52 Week High3.11
  • 52 Week High Date07/05/23
  • 52 Week Low0.95
  • 52 Week Low Date11/13/23
  • Market Cap118.004M
  • Shares Out90.08M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-12.67

RATIOS/PROFITABILITY

  • EPS (TTM)-1.84
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-1.36
  • EBITDA (TTM)-95.748M
  • ROE (TTM)-112.04%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunic Inc

 

Profile

MORE
Immunic, Inc. is a biotechnology company. The Company is focused on developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The Company’s s lead development program, vidofludimus calcium (IMU-838), is in phase III and phase II clinical trials for the treatment of relapsing and progressive multiple sclerosis, respectively, and has shown therapeutic activity in phase II clinical trials in patients...
Duane Nash M.D.
Executive Chairman of the Board
Daniel Vitt
President, Chief Executive Officer, Director
Glenn Whaley CPA
Chief Financial Officer
Inderpal Singh
General Counsel
Address
1200 Avenue Of The Americas, Suite 200
New York, NY
10036
United States

Top Peers

SYMBOLLASTCHG%CHG
VOR
Vor Biopharma Inc
1.72+0.02+1.18%
NVCT
Nuvectis Pharma Inc
6.62+0.27+4.25%
VTGN
Vistagen Therapeutics Inc
4.60+0.07+1.55%
LIFE
aTyr Pharma Inc
1.76+0.06+3.82%
VIGL
Vigil Neuroscience Inc
3.71+0.06+1.64%